01345.HK
Shanghai Pioneer Holding Ltd
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 1.95
−1.27%Year over year
Reported trailing growth
- Revenue
- -8.9%
- EBITDA
- -17.9%
- EBIT
- -18.5%
- EPS
- +20.3%
- Free cash flow
- +25.7%
- Operating cash flow
- +20.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.2%
- EBITDA
- -10.9%
- EBIT
- -15.4%
- Net income
- -21.4%
- EPS
- -20.8%
- Free cash flow
- +114.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026